5 results match your criteria: "University Tor Vergata of Roma[Affiliation]"
Int J Environ Res Public Health
August 2022
Clinical Infectious Diseases, Department of System Medicine, Tor Vergata University, 00133 Rome, Italy.
The results of tuberculosis (TB) screening and reactivation in a cohort of 323 adult patients undergoing haematopoietic stem cell transplantation (HSCT) from 2015 to 2019 at the University Hospital of Tor Vergata, Rome, Italy, were reported. A total of 260 patients, 59 (18.3%) autologous and 264 (81.
View Article and Find Full Text PDFCancers (Basel)
March 2021
Department of Biomedicine and Prevention, University Tor Vergata of Roma, 00133 Rome, Italy.
Measurable residual disease (MRD) is increasingly employed as a biomarker of quality of complete remission (CR) in intensively treated acute myeloid leukemia (AML) patients. We evaluated if a MRD-driven transplant policy improved outcome as compared to a policy solely relying on a familiar donor availability. High-risk patients (adverse karyotype, FLT3-ITD) received allogeneic hematopoietic cell transplant (alloHCT) whereas for intermediate and low risk ones (CBF-AML and NPM1-mutated), alloHCT or autologous SCT was delivered depending on the post-consolidation measurable residual disease (MRD) status, as assessed by flow cytometry.
View Article and Find Full Text PDFAesthet Surg J
June 2021
Department of Aesthetic Medicine, University Tor Vergata of Roma, Rome, Italy.
Background: Managing acne scars is a challenge and therapies are divided into nonsurgical and surgical. Highly Purified Technology Polynucleotides (PN-HPT) is a compound that contains a mixture of DNA polymers of different lengths. Numerous studies have shown that PN-HPT also serves as an energy source, thus influencing cellular growth and cell vitality.
View Article and Find Full Text PDFDermatol Ther
July 2020
Aesthetic Medicine Department, University Tor Vergata of Roma, Viale Oxfor 180, Rome, Italy.
Aesthet Surg J
September 2020
Department of Aesthetic Medicine, University Tor Vergata of Roma, Rome, Italy.
Background: Recent studies have shown that transcutaneous microfocused ultrasound with visualization is beneficial for noninvasive skin tightening, collagen regeneration, and lower face contour improvement.
Objectives: The primary study endpoint was the improvement of the laxity and ptosis face skin; the secondary endpoint was the improvement of wrinkles, texture, and hemoglobin content; and the third endpoint was the patient's responses to a patient satisfaction questionnaire.
Methods: Patients with soft to moderate skin laxity and ptosis of the face and neck were enrolled and their sex, ethnicity, age, Fitzpatrick skin type, and smoking habit recorded.